UroToday.com - ESMO 2024: PSMA-PET and PROMISE Re-Define Stage and Risk in Patients with Prostate Cancer. Read the Article
UroToday.com - Combining PSMA-PET and PROMISE to Re-Define Disease Stage and Risk in Patients with Prostate Cancer: A Multicentre Retrospective Study - Beyond the Abstract. Read the Article
UroToday.com - PROMISE Criteria: Enhanced Survival Prediction in Prostate Cancer with PSMA PET - Wolfgang Fendler. Read the Article
UroToday.com - PSMA PET and RLT 2024: The Role of PSMA PET in CRPC Patients - Wolfgang Fendler. Read the Article